Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor expression in U937 foam cells

Acta Pharmacologica Sinica

Volumn 24, Issue 6, 2003, Pages 610-614+624

  Yang, Peng Yuan ^b   Rui, Yao Cheng ^b   Jin, You Xin ^a   Li, Tie Jun ^b   Qiu, Yan ^b   Zhang, Li ^b   Wang, Jie Song ^b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b NONE

Author keywords

Antisense oligonucleotides; Endothelial growth factors; Enzyme linked immunosorbent assay; Foam cells; Northern blotting; U937 cells; Vascular endothelium

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ENDOTHELIAL CELL GROWTH FACTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULOTROPIN;

ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FOAM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MORPHOMETRICS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

FOAM CELLS; HUMANS; LIPOPROTEINS, LDL; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; U937 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0037495089     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
2. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular endothelial hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-39.
3. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
4. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-8.
5. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis. Nature 1992; 359: 843-5.
6. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor: cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 4149-56.
7. Yang PY, Rui YC, Zhang L, Li TJ, Qiu Y, Wang JS, et al. Expression of vascular endothelial growth factor in U937 foam cells and the inhibitory effect of dugs. Acta Pharm Sin 2002; 37: in press.
8. Qiu Y, Rui YC, Zhang L, Li TJ, Zhang WD. VEGF induced hyperpermeability in bovine aortic endothelial cell and inhibitory effect of salvianolic acid B. Acta Pharmacol Sin 2001; 22: 117-20.
9. Myers KJ, Dean NM. Sensible use of antisense: how to use oligonucleotides as reseach tools. Trends Pharmacol Sci 2000; 21: 19-23.
10. Dong F, Jin Y. Inhibition of angiogenesis with antisense ODN of VEGF. Chin J Oncol 1997; 19: 264-6.
11. Dong F, Xu X, Jing Y. Inhibition of VEGF expression by antisense oligodeoxynucleotides in vivo. Tumor 1997; 17: 63-6.
12. Zheng SX, Zhou LJ, Zhu XZ, Jin YX. Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor in human glioma cells. Acta Pharmacol Sin 2000; 21: 211-4.
13. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F. Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells. Biochim Biophys Acta 1991; 1096: 155-341.
14. Zhang L, Rui YC, Qiu Y, Li TJ. Effect of lysophatidylcholine on expression of vascular endothelial growth factor in ECV304 cells. Acta Pharmacol Sin 2001; 22: 335-9
15. Yang PY, Rui YC, Li K, Huang XH, Jiang JM, Yu L. Expression of intercellular adhesion molecule-1 in U937 foam cells and the inhibitory effect of imperatorin. Acta Pharmacol Sin 2002; 23: 327-30.
16. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Nat Acad Sci USA 1979; 76: 333-7.
17. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, et al. Location of PDGF-β protein in macrophage in all phases of atherogenesis. Science 1990; 248: 1009-12.
18. Barrett TB, Benditt EP. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 1988; 85: 2810-4.
19. Libby P, Friedman GB, Salomon RN. Cytokines as modulators of cell proliferation in fibrotic diseases. Am Rev Respir Dis 1989; 243: 393-6.
20. Ramos MA, Kuzuya M, Esaki T, Miura S, Satake S, Asai T, et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb 1998; 18: 1188-96.
21. Deshpande D, Rojanasakul Y. Antisense oligonucleotide therapeutics: a class of its own. Pharm News 1996; 3: 15-8.